Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1920 2
1932 1
1933 1
1935 1
1938 1
1940 1
1941 1
1943 1
1945 2
1946 4
1947 5
1948 2
1949 5
1950 6
1951 9
1952 8
1953 13
1954 6
1955 5
1956 6
1957 13
1958 13
1959 10
1960 6
1961 8
1962 11
1963 16
1964 16
1965 17
1966 22
1967 21
1968 26
1969 36
1970 31
1971 28
1972 39
1973 46
1974 32
1975 44
1976 38
1977 50
1978 50
1979 57
1980 60
1981 65
1982 79
1983 66
1984 67
1985 69
1986 75
1987 52
1988 44
1989 63
1990 93
1991 76
1992 97
1993 73
1994 85
1995 92
1996 83
1997 73
1998 71
1999 59
2000 73
2001 63
2002 85
2003 78
2004 88
2005 68
2006 110
2007 104
2008 96
2009 106
2010 122
2011 128
2012 140
2013 117
2014 153
2015 123
2016 129
2017 137
2018 119
2019 133
2020 81
Text availability
Article attribute
Article type
Publication date

Search Results

4,192 results
Results by year
Filters applied: . Clear all
Page 1
Targeting CD137 enhances the efficacy of cetuximab.
Kohrt HE, Colevas AD, Houot R, Weiskopf K, Goldstein MJ, Lund P, Mueller A, Sagiv-Barfi I, Marabelle A, Lira R, Troutner E, Richards L, Rajapaska A, Hebb J, Chester C, Waller E, Ostashko A, Weng WK, Chen L, Czerwinski D, Fu YX, Sunwoo J, Levy R. Kohrt HE, et al. Among authors: Levy R. J Clin Invest. 2019 Jun 3;129(6):2595. doi: 10.1172/JCI129689. Epub 2019 Jun 3. J Clin Invest. 2019. PMID: 31157621 Free PMC article. No abstract available.
Eradication of spontaneous malignancy by local immunotherapy.
Sagiv-Barfi I, Czerwinski DK, Levy S, Alam IS, Mayer AT, Gambhir SS, Levy R. Sagiv-Barfi I, et al. Among authors: Levy S, Levy R. Sci Transl Med. 2018 Jan 31;10(426):eaan4488. doi: 10.1126/scitranslmed.aan4488. Sci Transl Med. 2018. PMID: 29386357 Free PMC article.
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.
Kohrt HE, Houot R, Weiskopf K, Goldstein MJ, Scheeren F, Czerwinski D, Colevas AD, Weng WK, Clarke MF, Carlson RW, Stockdale FE, Mollick JA, Chen L, Levy R. Kohrt HE, et al. Among authors: Levy R. J Clin Invest. 2019 Jun 3;129(6):2595. doi: 10.1172/JCI129688. Epub 2019 Jun 3. J Clin Invest. 2019. PMID: 31157620 Free PMC article. No abstract available.
A Comprehensive Algorithm for Management of Neuropathic Pain.
Bates D, Schultheis BC, Hanes MC, Jolly SM, Chakravarthy KV, Deer TR, Levy RM, Hunter CW. Bates D, et al. Among authors: Levy RM. Pain Med. 2019 Jun 1;20(Suppl 1):S2-S12. doi: 10.1093/pm/pnz075. Pain Med. 2019. PMID: 31152178 Free PMC article. Review.
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY. Neelapu SS, et al. Among authors: Levy R. N Engl J Med. 2017 Dec 28;377(26):2531-2544. doi: 10.1056/NEJMoa1707447. Epub 2017 Dec 10. N Engl J Med. 2017. PMID: 29226797 Free PMC article. Clinical Trial.
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma.
Wolf Y, Bartok O, Patkar S, Eli GB, Cohen S, Litchfield K, Levy R, Jiménez-Sánchez A, Trabish S, Lee JS, Karathia H, Barnea E, Day CP, Cinnamon E, Stein I, Solomon A, Bitton L, Pérez-Guijarro E, Dubovik T, Shen-Orr SS, Miller ML, Merlino G, Levin Y, Pikarsky E, Eisenbach L, Admon A, Swanton C, Ruppin E, Samuels Y. Wolf Y, et al. Among authors: Levy R. Cell. 2019 Sep 19;179(1):219-235.e21. doi: 10.1016/j.cell.2019.08.032. Epub 2019 Sep 12. Cell. 2019. PMID: 31522890 Free PMC article.
Long-Term Durability of Transcatheter Aortic Valve Prostheses.
Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, Cunnington MS, Somers K, Brennan P, Manoharan G, Parker J, Aldalati O, Brecker SJ, Dowling C, Hoole SP, Dorman S, Mullen M, Kennon S, Jerrum M, Chandrala P, Roberts DH, Tay J, Doshi SN, Ludman PF, Fairbairn TA, Crowe J, Levy RD, Banning AP, Ruparelia N, Spence MS, Hildick-Smith D. Blackman DJ, et al. Among authors: Levy RD. J Am Coll Cardiol. 2019 Feb 12;73(5):537-545. doi: 10.1016/j.jacc.2018.10.078. J Am Coll Cardiol. 2019. PMID: 30732706 Free article.
Ketogenic diets for drug-resistant epilepsy.
Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Martin-McGill KJ, et al. Among authors: Levy RG. Cochrane Database Syst Rev. 2018 Nov 7;11(11):CD001903. doi: 10.1002/14651858.CD001903.pub4. Cochrane Database Syst Rev. 2018. PMID: 30403286 Free PMC article.
Predicting HLA class II antigen presentation through integrated deep learning.
Chen B, Khodadoust MS, Olsson N, Wagar LE, Fast E, Liu CL, Muftuoglu Y, Sworder BJ, Diehn M, Levy R, Davis MM, Elias JE, Altman RB, Alizadeh AA. Chen B, et al. Among authors: Levy R. Nat Biotechnol. 2019 Nov;37(11):1332-1343. doi: 10.1038/s41587-019-0280-2. Epub 2019 Oct 14. Nat Biotechnol. 2019. PMID: 31611695 Free PMC article.
4,192 results
Jump to page
Feedback